Vivo Capital, LLC Black Diamond Therapeutics, Inc. Transaction History

Vivo Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$29.47 - $35.0 $4.29 Million - $5.09 Million	-145,417 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$26.17 - $43.07 $129,070 - $212,421	-4,932 Reduced 3.28%	145,417 $4.4 Million
Q2 2020 Aug 14, 2020	SELL	$22.3 - $44.8 $2.27 Million - $4.56 Million	-101,770 Reduced 40.37%	150,349 $6.34 Million
Q1 2020 May 15, 2020	BUY	$18.18 - $39.48 $4.58 Million - $9.95 Million	252,119 New	252,119 $6.29 Million

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $95.9M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.